These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24155761)

  • 1. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.
    Hwang SO; Lee SW; Kim HJ; Kim WW; Park HY; Jung JH
    J Breast Cancer; 2013 Sep; 16(3):315-21. PubMed ID: 24155761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
    Guney IB; Dalci K; Teke ZT; Kucuker KA
    Ann Ital Chir; 2020; 91():458-464. PubMed ID: 32213685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Axillary SUV
    Karabacak U; Turkan H; Coskun G; Mollaoglu MC; Hasbek Z; Karadayi K
    J Coll Physicians Surg Pak; 2023 Apr; 33(4):374-379. PubMed ID: 37190706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer - a retrospective comparative study with PET/CT and breast MRI.
    Sae-Lim C; Wu WP; Chang MC; Lai HW; Chen ST; Chou CT; Liao CY; Huang HI; Chen ST; Chen DR; Hung CL
    World J Surg Oncol; 2024 Jan; 22(1):12. PubMed ID: 38183069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
    Ueda S; Tsuda H; Asakawa H; Omata J; Fukatsu K; Kondo N; Kondo T; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
    BMC Cancer; 2008 Jun; 8():165. PubMed ID: 18541009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
    Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA
    Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Axillary Ultrasound, MRI, and
    Aktaş A; Gürleyik MG; Aydın Aksu S; Aker F; Güngör S
    Eur J Breast Health; 2022 Jan; 18(1):37-47. PubMed ID: 35059590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the negative predictive value of positron emission tomography/computed tomography for axillary lymph node staging in breast cancer patients.
    Kim J; Cho H; Gwak G; Yang K; Kim JY; Shin YJ; Seo YY; Park I
    Asian J Surg; 2020 Jan; 43(1):193-200. PubMed ID: 30914155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.
    Kong EJ; Chun KA; Cho IH; Lee SJ
    Nucl Med Mol Imaging; 2010 Sep; 44(3):170-6. PubMed ID: 24899946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients.
    Dulgeroglu O; Arikan AE; Capkinoglu E; Kara H; Uras C
    Ann Ital Chir; 2022; 93():648-655. PubMed ID: 36617275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
    Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
    Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
    Heusner TA; Kuemmel S; Hahn S; Koeninger A; Otterbach F; Hamami ME; Kimmig KR; Forsting M; Bockisch A; Antoch G; Stahl A
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1543-50. PubMed ID: 19415270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Preoperative Ultrasonography and MRI Replace Sentinel Lymph Node Biopsy in Management of Axilla in Early Breast Cancer-a Prospective Study from a Tertiary Cancer Center.
    Panda SK; Goel A; Nayak V; Shaik Basha S; Pande PK; Kumar K
    Indian J Surg Oncol; 2019 Sep; 10(3):483-488. PubMed ID: 31496596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Axillary Lymph Node Involvement in Early-Stage Breast Cancer: Comparison between Staging
    Gupta R; Das J; Sinha S; Agarwal S; Sharma A; Ahmed R; Chanda A; Arun I; Ray S
    Indian J Nucl Med; 2023; 38(3):249-254. PubMed ID: 38046972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
    Monzawa S; Adachi S; Suzuki K; Hirokaga K; Takao S; Sakuma T; Hanioka K
    Ann Nucl Med; 2009 Dec; 23(10):855-61. PubMed ID: 19876704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer.
    Kumar R; Zhuang H; Schnall M; Conant E; Damia S; Weinstein S; Chandra P; Czerniecki B; Alavi A
    Nucl Med Commun; 2006 Mar; 27(3):231-6. PubMed ID: 16479242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.